NCT07371312

Brief Summary

Preimplantation genetic testing (PGT) is a reproductive genetic technique aimed at preventing the transmission of severe genetic disorders. In France, its use is strictly regulated and reserved for complex medical situations, often associated with challenging reproductive histories and significant psychological burden. Despite scientific advances, success rates in preimplantation genetic testing remain limited, making the care pathway a significant source of uncertainty regarding the future of the parental project.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
900

participants targeted

Target at P75+ for all trials

Timeline
23mo left

Started Mar 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress6%
Mar 2026Mar 2028

First Submitted

Initial submission to the registry

January 9, 2026

Completed
18 days until next milestone

First Posted

Study publicly available on registry

January 27, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

March 25, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 25, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 25, 2028

Last Updated

April 21, 2026

Status Verified

April 1, 2026

Enrollment Period

2 years

First QC Date

January 9, 2026

Last Update Submit

April 20, 2026

Conditions

Keywords

Preimplantation Genetic DiagnosisAssisted Reproductive TechnologyInfertilityReproductive OutcomesLive BirthPregnancy OutcomeParental ProjectPost-treatment Reproductive PathwaysLong-term OutcomesCouples Reproductive Decisions

Outcome Measures

Primary Outcomes (1)

  • Proportion of couples with at least one live-born child surviving ≥3 years after failure of preimplantation genetic diagnosis (PGD)

    Proportion of couples who achieved at least one pregnancy resulting in the birth of a live child who was alive at the age of 3 years or more, following failure of PGD care. PGD failure is defined as the absence of a live-born child resulting from PGD performed in the center. Outcome is assessed based on self-reported data collected via questionnaire, with verification when necessary.

    At least 3 years after the failure of PGD care (date of last PGD-related medical procedure in the center)

Secondary Outcomes (6)

  • Reason for discontinuation of preimplantation genetic diagnosis (PGD) care

    Baseline

  • Continuation of parental project after PGD failure

    Baseline

  • Post-PGD pathways followed after failure of PGD care

    From PGD failure to questionnaire completion

  • Occurrence of at least one pregnancy after PGD failure

    From PGD failure to questionnaire completion

  • Pregnancy occurring at least 3 years after PGD failure

    At least 3 years after PGD failure

  • +1 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Women belonging to couples managed for preimplantation genetic diagnosis (PGD) at the Paris PGD center (Hôpital Antoine Béclère - Necker, AP-HP) between 2006 and 2022, whose PGD care was discontinued without resulting in a live birth. Couples are identified from an institutional PGD database. All PGD indications are eligible.

You may qualify if:

  • Woman belonging to a couple who initiated at least one ovarian stimulation cycle for IVF (± ICSI) with preimplantation genetic diagnosis (PGD).
  • No further PGD-related procedures (oocyte retrieval or embryo transfer) performed in the center after December 31, 2022.
  • No live-born child resulting from PGD care.
  • Woman who expressed her free and informed non-opposition to participation.

You may not qualify if:

  • One or more live-born children resulting from PGD care in the center.
  • PGD involving gamete donation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Antoine Béclère

Clamart, 92140, France

RECRUITING

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Officials

  • Charlotte SONIGO, PhD

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 9, 2026

First Posted

January 27, 2026

Study Start

March 25, 2026

Primary Completion (Estimated)

March 25, 2028

Study Completion (Estimated)

March 25, 2028

Last Updated

April 21, 2026

Record last verified: 2026-04

Locations